Bridging Gaps Between Patients with COPD and their Healthcare Providers – Interview

Bridging Gaps Between Patients with COPD and their Healthcare Providers – Interview

 A Recent Survey* Reveals a Major Disconnect Between Patients and Their Physicians

This season will be one unlike any other for approximately 15.7 million people in the United States diagnosed with chronic obstructive pulmonary disease, or COPD, which is a progressive lung disease that makes it difficult to breathe.

With flu season here,

as well as dealing with seasonal allergens that can worsen symptoms, this can be a particularly stressful time for patients with COPD. In addition, patients with COPD are also at an increased risk of severe illness from COVID-19.

Patients with COPD have additional hurdles to jump.

Recent survey results* show that doctors and patients diagnosed with COPD aren’t having enough open conversations that are needed to help prevent the continued progression of their disease, and this could be costing them.

Specifically, there is a disconnect around the reporting of COPD

flare-ups, known as exacerbations, can be devastating events for patients. This disconnect could be due to a variety of factors, including the differences in the way that patients and doctors identify exacerbations, with only around a fifth of people living with COPD contacting a health professional when symptoms start.

Open, consistent communication and early prevention around exacerbations is critical because even a single exacerbation can have a negative impact on lung function.

Join me in a recent interview

with Pulmonologist Frank Trudo, MD, VP, US Medical Affairs, Respiratory & Immunology at AstraZeneca and Kristen Willard, Vice President, Public and Professional Education at the COPD Foundation, as they revealed the latest survey results on this topic and explained how to bridge the gap between patients with COPD and their doctors, while also recommending best practices for patients to communicate with their healthcare providers in order to be more proactive about their disease.

See the entire interview here:

For more information, go to

BIO: Frank J. Trudo, MD, MBA

Vice President of US Medical, Respiratory & Immunology

AstraZeneca LP

Frank Trudo, MD, MBA is Vice President of US Medical, Respiratory & Immunology at AstraZeneca, Wilmington, Delaware. Dr. Trudo completed Internal Medicine training at New York Hospital/Cornell Medical Center and completed fellowship training in Pulmonary, Critical Care and Sleep Medicine at the Hospital of the University of Pennsylvania. Dr. Trudo is board certified in Internal Medicine, Pulmonary Medicine and Sleep Medicine. He has also completed his MBA at Rutgers University Camden, New Jersey.

Dr. Trudo has had extensive clinical experience caring for patients and now is working to lead his team to advance new treatments to address the unmet medical needs for patients who have respiratory disease.

BIO: Kristen Willard, MS

Vice President of Public and Professional Education

COPD Foundation

Kristen Willard, MS is a health project manager with more than 20 years of experience in health research and project management. She is currently the Vice President of Public and Professional Education in the DC office of the COPD Foundation. She has a master’s degree in clinical psychology from Florida State University in Tallahassee, Florida.

At the COPD Foundation, Ms. Willard is responsible for overseeing the organization’s educational supports for those with COPD, their family members, and the health care professionals who work with them. Ms. Willard is particularly passionate about improving the lives of those with these illnesses, having lost both her father and grandmother to COPD.

*Based on 2019-2020 CHEST online quantitative survey of 401 HCPs (189 PCPs and 212 pulmonologists) and a 2020 COPD Foundation online quantitative survey of 428 people with a diagnosis of COPD.

Cynthia Tait

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.

%d bloggers like this: